New Research Highlights GP38’s Role in Enhancing CCHFV Treatments and Monoclonal Antibody Therapies
Recent advancements in the understanding of the Crimean-Congo hemorrhagic fever virus (CCHFV) have shed light on the role of its glycoprotein GP38, particularly in how...















